TAMPAX PEARL SUPER PLUS SCENTED TAMPONS

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-01-04 for TAMPAX PEARL SUPER PLUS SCENTED TAMPONS manufactured by Unknown.

Event Text Entries

[96694275] Tampax pearl super plus scented tampons gave me a recurrent yeast infection after use. After i researched it online, it is well known that scented tampons lead to bacterial vaginosis or yeast infections. Such products should not be on the market as yeast infections are embarrassing, anxiety inducing, and stressful to deal with while living a professional life. Date the person first started taking or using the product: (b)(6) 2017. Date the person stopped taking or using the product: (b)(6) 2017. Did the problem stop after the person reduced the dose or stopped taking or using the product: no. Did the problem return if the person started taking or using the product again: yes. Do you still have the product in case we need to evaluate it: yes. Why was the person using the product: menstruation.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5074419
MDR Report Key7168598
Date Received2018-01-04
Date of Report2018-01-03
Date of Event2017-12-24
Date Added to Maude2018-01-05
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Sequence Number: 0

Brand NameTAMPAX PEARL SUPER PLUS SCENTED TAMPONS
Generic NameTAMPAX PEARL SUPER PLUS SCENTED TAMPONS
Product CodeHIL
Date Received2018-01-04
Device Availability*
Device Eval'ed by MfgrI
Device Sequence No0
Device Event Key0
ManufacturerUNKNOWN

Device Sequence Number: 1

Brand NameTAMPAX PEARL SUPER PLUS SCENTED TAMPONS
Generic NameTAMPAX PEARL SUPER PLUS SCENTED TAMPONS
Product CodeHIL
Date Received2018-01-04
Device Availability*
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerTAMPAX


Patients

Patient NumberTreatmentOutcomeDate
10 2018-01-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.